Generally, the pathophysiology of schizophrenia is believed to be determined by imbalances in neurotransmitters, in particular dopamine and serotonin, and in four neural pathways in the brain ...

Medications that are currently available for schizophrenia generally target dopamine and are usually ... use genetic data to connect neural pathways with symptoms. In a world where identifying ...

Her seminal study on dopamine release in chronic cannabis users, published in Biological Psychiatry and cited over 152 times, has become a cornerstone in addiction and schizophrenia research.

Investigational drug SPN-820, which activates the mTORC1 pathway, failed to significantly reduce depressive symptoms compared ...